SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Documents Incorporated by Reference in ‘10-K’ Filing 950170-24-34812 · Filed re: Wednesday, 5/13/20
13
MAY


        

11  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
/A to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
 5/28/20  Norbe Todd                        4          Dir.,Off.²  1:5K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  Beaver John R                     4          Officer²    1:5K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  Wagner Elaine C                   4          Director²   1:6K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  Sato Garrett                      4          Director²   1:6K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  DiTolla Michael                   4          Director²   1:6K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  Lanman Richard B.                 4          Director²   1:7K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  Roper Jess                        4          Director²   1:6K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/28/20  Lord Jonathan T MD                4          Director²   1:6K   Biolase, Inc.                     DONNELLEY FIN… File16/FA 
 5/15/20  Biolase, Inc.                     8-K:5       5/13/20    1:71K                                    ActiveDisclosure/FA      
 4/23/20  Biolase, Inc.                     DEF 14A     5/13/20    1:1.5M                                   ActiveDisclosure/FA      
 4/13/20  Biolase, Inc.                     PRE 14A     5/13/20    1:1.5M                                   ActiveDisclosure/FA      
____________
 ¹  Filing/Form Types: 
Type emoji
/A
  4    Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  DEF 14A    Definitive Proxy Statement — Schedule 14A.
  PRE 14A    Preliminary Proxy Statement — Schedule 14A.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 12:25:48.3pm ET